MLchartDataset catalogue

Belrapzo

Term · Oncology and biomedicine · MLC-T-ONC-000977

A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Belrapzo damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called bendamustine hydrochloride, Bendeka, and Treanda.

Table 1. Record
IdentifierMLC-T-ONC-000977
FieldOncology and biomedicine
Synonymsbendamustine hydrochloride; Bendeka; Treanda
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000977",
  "term": "Belrapzo",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Belrapzo damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called bendamustine hydrochloride, Bendeka, and Treanda.",
  "synonyms": [
    "bendamustine hydrochloride",
    "Bendeka",
    "Treanda"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/belrapzo/"
}

Record 3,408 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.